Hepatitis C virus infection and autoimmune diseases

International Journal of General Medicine

Volumn 5, Issue , 2012, Pages 903-907

  Paroli, Marino ^a   Iannucci, Gino ^a   Accapezzato, Daniele ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autoimmune diseases; Hepatitis C virus; Immune regulation

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CHRONIC HEPATITIS; CLINICAL OBSERVATION; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; THYROID DISEASE;

EID: 84875373355     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S37580     Document Type: Review

References (57)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244(4902):359-362.
2. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis. 2007;39(1):2-17.
3. Zignego AL, Brechot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol. 1999;31(2):369-376.
4. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 1999;42(10):2204-2212.
5. Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 1992;117(7):573-577.
6. Ferri C, Monti M, La Civita L, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood. 1993;82(12):3701-3704.
7. Zignego AL, Ferri C, Giannini C, et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol. 1997;142(3):545-555.
8. Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood. 1994;84(9):3047-3053.
9. Ferri C, Monti M, La Civita L, et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia. Eur J Clin Invest. 1994;24(11):781-784.
10. Luppi M, Grazia Ferrari M, Bonaccorsi G, et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia. 1996;10(2):351-355.
11. Zuckerman E, Zuckerman T, Levine AM, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med. 1997;127(6):423-428.
12. Monti G, Pioltelli P, Saccardo F, et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med. 2005;165(1):101-105.
13. Andreone P, Zignego AL, Cursaro C, et al. Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. Ann Intern Med. 1998;129(4):294-298.
14. Terrier B, Joly F, Vazquez T, et al. Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity. J Immunol. 2011;187(12):6550-6563.
15. Franceschini D, Del Porto P, Piconese S, et al. Polyfunctional type-1,-2, and-17 CD8(+) T cell responses to apoptotic self-antigens correlate with the chronic evolution of hepatitis C virus infection. PLoS Pathog. 2012;8(6):e1002759.
16. Roughan JE, Reardon KM, Cogburn KE, Quendler H, Pockros PJ, Law M. Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells. Clin Vaccine Immunol. 2012;19(7):1027-1037.
17. Tu Z, Hamalainen-Laanaya HK, Nishitani C, Kuroki Y, Crispe IN, Orloff MS. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation. Int Immunol. 2012;24(2):97-106.
18. Sutti S, Vidali M, Mombello C, Sartori M, Ingelman-Sundberg M, Albano E. Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry. J Hepatol. 2010;53(3):431-438.
19. Choubey D, Moudgil KD. Interferons in autoimmune and inflammatory diseases: regulation and roles. J Interferon Cytokine Res. 2011;31(12):857-865.
20. Pavan MH, Pavin EJ, Goncales FL Jr, Wittmann DE. Virus C genotype predisposes to primary hypothyroidism during interferon-alpha treatment for chronic hepatitis C. Braz J Infect Dis. 2011;15(5):449-456.
21. Costelloe SJ, Wassef N, Schulz J, et al. Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapy. Clin Endocrinol (Oxf). 2010;73(2):249-256.
22. Tran HA, Reeves GE. The influence of hepatitis C infection and interferon-alpha therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case report. 2009;2(1):12.
23. Nagao Y, Hiromatsu Y, Nakashima T, Sata M. Graves' ophthalmopathy and tongue cancer complicated by PEG-interferon alpha-2b and ribavirin therapy for chronic hepatitis C: a case report and review of the literature. Mol Med Report. 2008;1(5):625-631.
24. Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, Liaw YF. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol (Oxf). 1999;50(4):503-509.
25. Ganne-Carrie N, Medini A, Coderc E, et al. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmun. 2000;14(2):189-193.
26. Salazar LA, Garcia-Samper X, Suarez-Carpio R, et al. Hypothyroidism in noninterferon treated-HCV infected individuals is associated with abnormalities in the regulation of Th17 Cells. Hepat Res Treat. 2010;2010:971095.
27. Lenzi M, Johnson PJ, McFarlane IG, et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet. 1991;338(8762):277-280.
28. Prentice LM, Phillips DI, Sarsero D, Beever K, McLachlan SM, Smith BR. Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol (Copenh).1990;123(5):493-498.
29. Minelli R, Braverman LE, Giuberti T, et al. Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment. Clin Endocrinol (Oxf). 1997;47(3):357-361.
30. Preziati D, La Rosa L, Covini G, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol. 1995;132(5):587-593.
31. Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf). 1996;44(6): 635-642.
32. Akeno N, Blackard JT, Tomer Y. HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun. 2008;31(4):339-344.
33. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science. 1998;282(5390):938-941.
34. Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33(6):355-374.
35. Rosner I, Rozenbaum M, Toubi E, Kessel A, Naschitz JE, Zuckerman E. The case for hepatitis C arthritis. Semin Arthritis Rheum. 2004;33(6):375-387.
36. Zehairy M, Soliman E, Daghaidy A. Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy. Rheumatol Int. November 9, 2011. [Epub ahead of print.]
37. Ezzat WM, Raslan HM, Aly AA, Emara NA, El Menyawi MM, Edrees A. Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy. Rheumatol Int. 2011;31(1):65-69.
38. Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sjogren's syndrome: novel aspects on pathogenesis. Immunol Lett. 2011;141(1):1-9.
39. Meltzer M, Franklin EC. Cryoglobulinemia-a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med. 1966;40(6):828-836.
40. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia-a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med. 1966;40(6):837-856.
41. Koike K, Moriya K, Ishibashi K, et al. Sialadenitis histologicly resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci U S A. 1997;94(1):233-236.
42. Scott CA, Avellini C, Desinan L, et al. Chronic lymphocytic sialoadenitisin HCV-related chronic liver disease: comparison of Sjogren's syndrome. Histopathology. 1997;30(1):41-48.
43. Vitali C. Immunopathologic differences of Sjogren's syndrome versus sicca syndrome in HCV and HIV infection. Arthritis Res Ther. 2011; 13(4):233.
44. Ramos-Casals M, Garcia-Carrasco M, Cervera R, et al. Hepatitis C virus infection mimicking primary Sjogren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore). 2001; 80(1):1-8.
45. Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev. 2005;4(1):8-15.
46. Matsumoto S, Nakajima S, Nakamura K, et al. Interferon treatment on glomerulonephritis associated with hepatitis C virus. Pediatr Nephrol. 2000;15(3/4):271-273.
47. Romas E, Power DA, Machet D, Powell H, d'Apice AJ. Membranous glomerulonephritis associated with hepatitis C virus infection in an adolescent. Pathology. 1994;26(4):399-402.
48. Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest. 1995;25(12):910-914.
49. Bagan JV, Ramon C, Gonzalez L, et al. Preliminary investigation of the association of oral lichen planus and hepatitis C. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(5):532-536.
50. Mignogna MD, Lo Muzio L, Favia G, Mignogna RE, Carbone R, Bucci E. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol. 1998;37(8):575-578.
51. Stubgen JP. Immune-mediated myelitis associated with hepatitis virus infections. J Neuroimmunol. 2011;239(1/2):21-27.
52. Sim JE, Lee JB, Cho YN, Suh SH, Kim JK, Lee KY. A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection. Yonsei Med J. 2012;53(4):856-858.
53. Stubgen JP. Neuromuscular diseases associated with chronic hepatitis C virus infection. J Clin Neuromuscul Dis. 2011;13(1):14-25.
54. Hemmati I, Yoshida E, Shojania K. Relapsing polychondritis associated with hepatitis C virus infection. Clin Rheumatol. 2012;31(2):391-394.
55. Dimitroulis D, Valsami S, Stamopoulos P, Kouraklis G. Immunologic HCV-associated thrombocytopenia: short review. Clin Dev Immunol. 2012;2012:378653.
56. Aref S, Ibrahem L, El Menshawy N, Bassam A. Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia. Hematology. 2012;17(2):118-121.
57. Olariu M, Olariu C, Olteanu D. Thrombocytopenia in chronic hepatitis C. J Gastrointestin Liver Dis. 2010;19(4):381-385.